Design and analysis of stably integrated reporters for inducible transgene expression in human T cells and CAR NK-cell lines
Abstract Background Cytotoxic activity of T- and NK-cells can be efficiently retargeted against cancer cells using chimeric antigen receptors (CARs) and rTCRs. In the context of solid cancers, use of armored CAR T- and NK cells secreting additional anti-cancer molecules such as cytokines, chemokines...
Saved in:
Main Authors: | Sergey V. Kulemzin (Author), Daria A. Matvienko (Author), Artur H. Sabirov (Author), Arpine M. Sokratyan (Author), Daria S. Chernikova (Author), Tatyana N. Belovezhets (Author), Anton N. Chikaev (Author), Aleksandr V. Taranin (Author), Andrey A. Gorchakov (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2019-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biomarkers as targets for CAR-T/NK cell therapy in AML
by: Ruonan Shao, et al.
Published: (2023) -
CAR-NK cells for cancer immunotherapy: from bench to bedside
by: Leisheng Zhang, et al.
Published: (2022) -
Site-specific transgene integration in chimeric antigen receptor (CAR) T cell therapies
by: Hamed Dabiri, et al.
Published: (2023) -
Cholesterol metabolism: a positive target to revoke the function of exhausted CAR-NK cells in tumor microenvironment
by: Jingfeng Liu, et al.
Published: (2024) -
Chimeric antigen receptor-natural killer (CAR-NK) cell immunotherapy: A bibliometric analysis from 2004 to 2023
by: Wangshu Li, et al.
Published: (2024)